scispace - formally typeset
L

Luca Falzone

Researcher at University of Catania

Publications -  89
Citations -  4128

Luca Falzone is an academic researcher from University of Catania. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 27, co-authored 65 publications receiving 2337 citations.

Papers
More filters
Journal ArticleDOI

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.

TL;DR: Today, cancer research is always aimed at the study and development of new therapeutic approaches for cancer treatment, and several researchers are focused on the development of cell therapies, anti-tumor vaccines, and new biotechnological drugs that have already shown promising results in preclinical studies, therefore, in the near future, it will certainly assist to a new revolution in the field of medical oncology.
Journal ArticleDOI

Cutaneous melanoma: From pathogenesis to therapy (Review)

TL;DR: The epidemiological features of cutaneous melanoma along with the biological mechanisms involved in its development and progression are summarized and the current state-of-the-art of advanced stage melanoma treatment strategies and the currently available evidence of the use of predictive and prognostic biomarkers are discussed.
Journal ArticleDOI

Gut Microbiota and Cancer: From Pathogenesis to Therapy

TL;DR: Novel strategies integrating probiotics, such as LGG, with conventional anti-cancer therapies are strongly encouraged, because of the tight association between gut microbiota and tumorigenesis, as well as Gut microbiota and anti- cancer therapy.
Journal ArticleDOI

Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection.

TL;DR: In this article, the authors evaluated the sensitivity of droplet digital PCR (ddPCR) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and concluded that ddPCR showed higher sensitivity and specificity compared to RT-q-PCR for the diagnosis of COVID-19 infection in false negative samples with low viral load.
Journal ArticleDOI

Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.

TL;DR: Both benefits and pitfalls of molecular biology and proteomics analyses are discussed, including the different mass spectrometry-based analytical techniques, highlighting how these investigation strategies are powerful tools to study the biology of glioblastoma, as well as to develop advanced methods for the management of this pathology.